Accelerate Diagnostics reported 12.91M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 7M
Accelerate Diagnostics AXDX:US 12.91M 1.12M
Becton, Dickinson and BDX:US $ 1.24B 89M
Bio Rad Laboratories BIO:US $ 209.28M 18.12M
Bruker BRKR:US $ 134.8M 2.9M
Danaher DHR:US $ 1.97B 90M
Exact Sciences EXAS:US $ 362.46M 91.41M
Genmark Diagnostics GNMK:US $ 12.4M 2.06M
Hologic HOLX:US $ 260M 39.6M
Illumina ILMN:US $ 413M 39M
Luminex LMNX:US $ 36.18M 1.04M
Meridian Bioscience VIVO:US $ 18.17M 1.29M
Myriad Genetics MYGN:US $ 134.8M 10.7M
Nanostring Technologies NSTG:US $ 26.86M 56K
Oxford Immunotec Global OXFD:US 11.97M 934K
Pacific Biosciences Of California PACB:US $ 29.06M 2.92M
Perkinelmer PKI:US $ 281.82M 30.41M
Quidel QDEL:US $ 59.24M 5.5M
Thermo Fisher Scientific TMO:US $ 1.61B 196M